NAOV
NanoVibronix, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.90
+1.06%Margins
Gross margin
30.0%
EBITDA margin
-236.4%
EBIT margin
-351.8%
Net margin
-133.0%
FCF margin
-271.2%
-8.4%
Return on equity
-6.6%
Return on assets
-20.7%
Return on invested capital
0.05x
Asset turnover
-$7.2M
Cash from operations
$14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025